|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0742 EUR | +5.10% |
|
+2.91% | +13.80% |
| 06:35am | TME Pharma Secures 12-month Loan Extension | MT |
| Jan. 05 | TME Pharma N.V. Provides Update on Its Activities | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"
| Capitalization | 6.13M 7.11M 5.54M 5.31M 9.65M 655M 10.09M 65.41M 26.23M 313M 26.7M 26.12M 1.12B | P/E ratio 2023 |
-0.17x | P/E ratio 2024 | -0.47x |
|---|---|---|---|---|---|
| Enterprise value | 2.89M 3.36M 2.61M 2.51M 4.55M 309M 4.76M 30.86M 12.38M 148M 12.6M 12.33M 531M | EV / Sales 2023 |
-
| EV / Sales 2024 | - |
| Free-Float |
9.94% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +5.10% | ||
| 1 week | +2.91% | ||
| Current month | +7.54% | ||
| 1 month | -4.63% | ||
| 3 months | +34.91% | ||
| 6 months | -28.79% | ||
| Current year | +13.80% |
| 1 week | 0.07 |  | 0.09 |
| 1 month | 0.06 | | 0.09 |
| Current year | 0.06 | | 0.09 |
| 1 year | 0.05 | | 0.15 |
| 3 years | 0.05 | | 2.2 |
| 5 years | 0.05 | | 52 |
| 10 years | 0.05 | | 2,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2025-06-24 | |
| Chief Tech/Sci/R&D Officer | 75 | 2017-01-31 | |
| Chief Executive Officer | 56 | 2010-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | 2019-06-24 | |
Susan Coles
BRD | Director/Board Member | 60 | 2021-06-23 |
Lee Schalop
BRD | Director/Board Member | - | 2024-06-26 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.10% | +2.91% | +1.23% | -93.55% | 7.7M | |
| -1.09% | -5.94% | -8.36% | -7.72% | 45.49B | |
| -1.15% | -5.42% | +22.53% | +36.40% | 33.41B | |
| -4.00% | -14.47% | +15.30% | +44.37% | 31.32B | |
| +1.46% | +1.63% | -6.18% | -12.72% | 29.29B | |
| -0.30% | -3.86% | +165.34% | +350.23% | 19.5B | |
| -0.56% | -1.64% | +72.33% | +118.89% | 14.77B | |
| +1.37% | +4.14% | +41.19% | +153.42% | 13.36B | |
| -1.64% | -6.48% | +21.59% | +2.95% | 13.21B | |
| +0.15% | -9.41% | +130.45% | +113.61% | 12.23B | |
| Average | -0.12% | -3.07% | +45.54% | +70.59% | 21.26B | |
| Weighted average by Cap. | -1.00% | -4.45% | +34.78% | +65.59% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | - | - |
| Net income | -6.74M -7.81M -6.08M -5.83M -10.59M -719M -11.08M -71.82M -28.8M -344M -29.31M -28.68M -1.23B | -5.72M -6.63M -5.17M -4.95M -9M -611M -9.41M -61.01M -24.46M -292M -24.9M -24.37M -1.05B |
| Net Debt | -1.08M -1.25M -974K -934K -1.7M -115M -1.77M -11.5M -4.61M -55.12M -4.7M -4.59M -198M | -3.24M -3.76M -2.93M -2.8M -5.1M -346M -5.33M -34.54M -13.85M -166M -14.1M -13.8M -594M |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-09 | 0.0742 € | +5.10% | 1,821,883 |
| 26-03-06 | 0.0706 € | -3.95% | 257,922 |
| 26-03-05 | 0.0735 € | +6.06% | 120,309 |
| 26-03-04 | 0.0693 € | -4.94% | 81,929 |
| 26-03-03 | 0.0729 € | +1.11% | 125,047 |
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALTME Stock
Select your edition
All financial news and data tailored to specific country editions
